Streamline Compliance and Quality in Pharmaceuticals Using ETQ

In this webinar, you will learn:

Pharmaceutical Quality Framework
Management Responsibility
Ongoing Enhancement of Process Efficiency and Product Integrity
Sustained Advancement of the Pharmaceutical Quality Framework

We are pleased to extend an invitation to our upcoming webinar focused on enhancing compliance and quality standards within the pharmaceutical industry through the utilization of ETQ solutions. This informative session will delve into the critical importance of maintaining regulatory compliance while ensuring the highest quality of products. Participants will gain insights into how ETQ can streamline processes, reduce risks, and improve overall operational efficiency, thereby fostering a culture of continuous improvement in pharmaceutical practices.

Join Manoj Joshi, Life Science Industry Expert, as he discusses his experience in addressing the unique quality challenges in pharmaceutical organizations like yours. He will be joined by Suryakant Bhavikatty, Senior Quality Consultant, QMS, ETQ.

Speakers

	Manoj Joshi (Guest Speaker) Life Science Industry Expert Results-driven professional with three decades of experience in end-to-end automation and digitalization, specializing in regulatory compliance, computer system validation and computer software assurance, risk management and quality management, particularly within the pharmaceutical industry.
	Suryakant Bhavikatty Senior Quality Consultant, QMS, ETQ, a Part of Hexagon

Fill in the form below to register.

First Name

Last Name

Company

Business Email

Phone

Country

State

Industry

I consent to receive electronic marketing communications on products, services, publications, and events.

Comments

Our Privacy Policy describes how we process Personal Data about you. It also provides information on how you may exercise any of your rights as a Data Subject. You have the right to withdraw your consent at any time by clicking on the "Unsubscribe" link within the electronic marketing communications sent to you. By submitting this form, you agree to our Terms of Use.